Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

The Pharma & Biopharma Outsourcing Association announced its support of legislation that would preserve FDA user fees from sequestration.

PBOA Supports Legislation to Protect FDA User Fees

SGS Life Science Services adds analytical methods to identify amino acid impurities in bio/pharmaceutical manufacturing at facility in Germany.

SGS Adds Amino Acid Analysis at German Facility

Novasep has entered into an agreement with Celladon to provide scale-up and pre-validation studies for the drug substance for MYDICAR.

Novasep to Manufacture Celladon's Mydicar API

Jim J. Zhang, Ph.D. is president and managing director of JZMed, jz@jzmedi.com.

The fast growth of the global biopharmaceutical market has prompted global pharmaceutical and biotechnology companies to increase their R&D investment in biologics.

The Global Biomanufacturing Outsourcing Market

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Protecting workers, patients, and the environment requires advanced technologies.

Minimizing Risk during HPAPI Manufacture

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

CMOs Plan for Capacity Expansions

The company has increased capacity for cold storage and controlled drug substances handling at its European facilities.

Catalent Expands Clinical Packaging Capabilities in Europe

SGS has invested in additional modules for its COBAS 6000 analysis system in a move to expand its biomarker analytical capabilities at its Poitiers facility in France.

SGS Expands Biomarker Testing Capabilities at Poitiers Facility

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Careful selection of a contract packager should include interviews, surveys, and on-site visits.

Choosing a Contract Packager

The agency releases five draft guidance documents related to drug compounding and repackaging.